Success Metrics

Clinical Success Rate
87.0%

Based on 20 completed trials

Completion Rate
87%(20/23)
Active Trials
17(29%)
Results Posted
25%(5 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_2
7
12%
Ph not_applicable
20
34%
Ph phase_1
4
7%
Ph early_phase_1
4
7%
Ph phase_4
2
3%

Phase Distribution

8

Early Stage

7

Mid Stage

2

Late Stage

Phase Distribution37 total trials
Early Phase 1First-in-human
4(10.8%)
Phase 1Safety & dosage
4(10.8%)
Phase 2Efficacy & side effects
7(18.9%)
Phase 4Post-market surveillance
2(5.4%)
N/ANon-phased studies
20(54.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

20 of 24 finished

Non-Completion Rate

16.7%

4 ended early

Currently Active

17

trials recruiting

Total Trials

58

all time

Status Distribution
Active(20)
Completed(20)
Terminated(4)
Other(14)

Detailed Status

Completed20
Recruiting14
unknown14
Active, not recruiting3
Not yet recruiting3
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
58
Active
17
Success Rate
87.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (10.8%)
Phase 14 (10.8%)
Phase 27 (18.9%)
Phase 42 (5.4%)
N/A20 (54.1%)

Trials by Status

active_not_recruiting35%
not_yet_recruiting35%
terminated35%
recruiting1424%
completed2034%
unknown1424%
withdrawn12%

Recent Activity

Clinical Trials (58)

Showing 20 of 58 trialsScroll for more
NCT06303921Early Phase 1

Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503

Recruiting
NCT04621357Not Applicable

Influence of Cerebral Oedema in Intracerebral Haemorrhage

Recruiting
NCT07462507Phase 2

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Recruiting
NCT07358819Not Applicable

Quantitative 3D UltraSound Brain Imaging: Development of New Bedside Biomarkers to Better Predict Neurodevelopmental Outcomes in Preterm Infants

Not Yet Recruiting
NCT04432597Phase 1

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Active Not Recruiting
NCT04012411Not Applicable

Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease

Recruiting
NCT04691011Not Applicable

New Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis

Completed
NCT06865677Phase 2

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Terminated
NCT07340736Not Applicable

Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Correlates

Not Yet Recruiting
NCT04109131Not Applicable

A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours

Recruiting
NCT04453917Not Applicable

Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy

Completed
NCT03269721

COPD-Related Physiology and the Brain

Completed
NCT06932809Early Phase 1

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

Recruiting
NCT03887169Phase 1

Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.

Completed
NCT06032026Early Phase 1

Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

Recruiting
NCT06461065Not Applicable

Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Different Early Treatment Modalities in Children With Type 1 Diabetes (T1DM)

Recruiting
NCT07167732

CTNNB1 Neurodevelopmental Syndrome - Natural History Study

Recruiting
NCT07167953Not Applicable

The Spiral MRI Study

Not Yet Recruiting
NCT05012098Phase 2

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

Completed
NCT04852744Not Applicable

NEUROIMAGING OF ADOLESCENT BORDERLINE PERSONALITY DISORDER WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
58